Sign in

CIK 0000914475

  • Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330525145
Phone
+1 858-617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-08 Lloyd-Smith Malcolm Chief Regulatory Officer Sale −1,015 $116.87 $119K 32,510
2021-02-08 Lloyd-Smith Malcolm Chief Regulatory Officer Grant or award · Stock Option +31,880 31,880
2021-02-08 Lloyd-Smith Malcolm Chief Regulatory Officer Grant or award · Restricted Stock Unit +5,314 5,314
2021-02-08 Grigoriadis Dimitri E. Chief Research Officer Sale −687 $116.67 $80K 83,456
2021-02-08 Grigoriadis Dimitri E. Chief Research Officer Sale −803 $116.69 $94K 84,178
2021-02-08 Grigoriadis Dimitri E. Chief Research Officer Sale −1,218 $116.70 $142K 85,273
2021-02-08 Grigoriadis Dimitri E. Chief Research Officer Grant or award · Stock Option +38,256 38,256
2021-02-08 Grigoriadis Dimitri E. Chief Research Officer Grant or award · Restricted Stock Unit +6,376 6,376
2021-02-08 GORMAN KEVIN CHARLES Chief Executive Officer Sale −2,875 $116.79 $336K 446,144
2021-02-08 GORMAN KEVIN CHARLES Chief Executive Officer Sale −4,343 $116.74 $507K 450,051
2021-02-08 GORMAN KEVIN CHARLES Chief Executive Officer Sale −3,248 $116.71 $379K 452,972
2021-02-08 GORMAN KEVIN CHARLES Chief Executive Officer Grant or award · Stock Option +103,609 103,609
2021-02-08 GORMAN KEVIN CHARLES Chief Executive Officer Grant or award · Restricted Stock Unit +17,269 17,269
2021-02-05 Gano Kyle Chief Business Development Off Sale −703 $113.77 $80K 98,663
2021-02-05 Gano Kyle Chief Business Development Off Sale −1,974 $114.09 $225K 100,439
2021-02-05 Bozigian Haig P. Chief Development Officer Sale −704 $113.79 $80K 153,328
2021-02-05 BENEVICH ERIC Chief Commercial Officer Sale −809 $114.03 $92K 16,434
2021-02-05 Cooke Julie Chief Human Resources Officer Sale −605 $113.86 $69K 12,125
2021-02-05 Lloyd-Smith Malcolm Chief Regulatory Officer Sale −865 $114.15 $99K 29,675
2021-02-05 Grigoriadis Dimitri E. Chief Research Officer Sale −605 $113.76 $69K 82,169

Page 61 of 62 · 1,221 trades